Chimerix, Inc.
Pyrrolopyrimidine nucleosides and analogs thereof
Last updated:
Abstract:
The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein R.sub.c and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
6 Aug 2019
Issue date:
9 Mar 2021